These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 26315541

  • 41. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY, Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT.
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [Abstract] [Full Text] [Related]

  • 42. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
    Zhuang LK, Yang YT, Ma X, Han B, Wang ZS, Zhao QY, Wu LQ, Qu ZQ.
    Cell Death Dis; 2016 Apr 21; 7(4):e2203. PubMed ID: 27100897
    [Abstract] [Full Text] [Related]

  • 43. miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3.
    Su J, Wang Q, Liu Y, Zhong M.
    Mol Cell Biochem; 2014 Jul 21; 392(1-2):289-96. PubMed ID: 24671492
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
    Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, Man K, Ng IO.
    Gastroenterology; 2011 Jan 21; 140(1):322-31. PubMed ID: 20951699
    [Abstract] [Full Text] [Related]

  • 47. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

  • 48. miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3.
    Xue J, Niu YF, Huang J, Peng G, Wang LX, Yang YH, Li YQ.
    Tumour Biol; 2014 Dec 22; 35(12):12103-7. PubMed ID: 25142234
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
    Zhang L, Wang W, Li X, He S, Yao J, Wang X, Zhang D, Sun X.
    Int J Oncol; 2016 Jun 22; 48(6):2425-34. PubMed ID: 27035278
    [Abstract] [Full Text] [Related]

  • 54. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 22; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
    Zhou X, Ji G, Ke X, Gu H, Jin W, Zhang G.
    Dig Dis Sci; 2015 Nov 22; 60(11):3271-82. PubMed ID: 26233544
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.